Wong ND

• The 2025 Guideline for the Management of Patients With Acute Coronary Syndromes: Asian Perspective 2025-06-04
  No abstract
  Mitsuaki Sawano
• U.S. Eligibility and Preventable Cardiovascular, Diabetes, and Kidney Outcomes From Semaglutide in the SELECT Trial 2025-05-22
  No abstract
  Hongmei Yan
• Lipoprotein(a) and Atherosclerosis: Not So Little Anymore With Bigger Data 2025-04-23
  No abstract
  Nathan D Wong
• AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality: an AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA) 2025-04-12
  CONCLUSION: AI-enabled liver steatosis measurement in CAC scans provides opportunistic and actionable information for early detection of individuals at elevated risk of CVD events and mortality, without additional radiation.
  Morteza Naghavi
• Editors' Message - March 2025 2025-04-09
  No abstract
  Nathan D Wong
• Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethyl 2025-03-31
  INTRODUCTION: Icosapent ethyl (IPE) is indicated for the treatment of severe hypertriglyceridemia (triglycerides ≥500 mg/dl) and for reducing the risk of cardiovascular (CV) events in statin-treated adults with moderately elevated triglycerides (150-499 mg/dl) and established CV disease [secondary prevention (SP)] or diabetes with CV risk factors [primary prevention (PP)]. We describe real-world characteristics of US […]
  Peter P Toth
• Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea: Implications for East Asians? 2025-03-06
  The management of atherosclerotic cardiovascular disease (ASCVD) in the United States is currently based upon large epidemiological studies in primarily non-Hispanic White subjects. Although this strategy provides a uniform approach that is simpler to implement, it may result in inappropriately targeting certain Asian populations for treatment based on inaccurate ASCVD risk estimation. In this state-of-the-art […]
  Patricia K Nguyen
• Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: The <em>All of Us</em> research program 2025-02-24
  CONCLUSIONS: Despite some progress in managing individual CVD risk factors in T2DM, overall composite risk factor control remains poor, especially among underrepresented and socioeconomically disadvantaged groups. The findings highlight the necessity for integrated healthcare strategies that address both medical and social needs to improve control of CVD risk factors and outcomes in T2DM.
  Frances Golden
• Cardiovascular Disease Risk Among Older Asian, Native Hawaiian, Pacific Islanders Lung Cancer Survivors 2025-02-20
  CONCLUSION: While ANHPI lung cancer patients had lower risks of heart failure and ischemic heart disease than NHW lung cancer patients, heterogeneity in risk was observed among ANHPI subgroups. Further research is needed to investigate the reasons for the higher risk of several CVDs among Pacific Islander, South Asian, and Southeast Asian lung cancer patients.
  Yancen Pan
• Prevalence and Mortality Trends of Hypertension Subtypes Among US Adults: An Analysis of the National Health and Nutrition Examination Survey 2025-01-31
  CONCLUSIONS: Our data demonstrate the continuing importance of HTN subtype transitions across age and their differences in predicting future CVD and total mortality.
  Kevin S Tang
• 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association 2025-01-27
  CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
  Seth S Martin
• Lipoprotein(a) Atherosclerotic Cardiovascular Disease Risk Score Development and Prediction in Primary Prevention From Real-World Data 2025-01-24
  CONCLUSIONS: We show the feasibility of developing an improved ASCVD risk prediction model incorporating Lp(a) based on a real-world adult clinic population. The inclusion of Lp(a) in ASCVD prediction models can reclassify risk in patients who may benefit from more intensified ASCVD prevention efforts.
  Wenjun Fan
• American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions 2025-01-13
  Groundbreaking strategies for preventive cardiology were showcased at the 2024 American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention held in Salt Lake City, Utah, from August 2nd to 4th, 2024. The event featured 69 moderators and 13 scientific sessions comprised of 98 topics, 36 satellite events, 133 poster presentations, and 27 […]
  Akhil A Chandra
• United States Pooled Cohort Cardiovascular Disease Risk Scores in Adults With Diabetes Mellitus 2025-01-06
  CONCLUSIONS: Our U.S. pooled cohort DMRS for predicting CVD events demonstrated good predictive performance for assessing CVD risk in adults with DM.
  Yanglu Zhao
• AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI 2025-01-01
  CONCLUSIONS: AI-CAC automated LA volumetry and CMRI LA volume measured by human experts similarly predicted incident AF and stroke over 15 years. Further studies to investigate the clinical utility of AI-CAC for AF and stroke prediction are warranted.
  Morteza Naghavi
• Interplay between lifestyle factors and polygenic risk for incident coronary heart disease in a large multiethnic cohort 2024-11-25
  CONCLUSIONS: Lifestyle and polygenic risk together influence the risk of incident CHD. Our results support consideration of polygenic risk in lifestyle interventions because those with high polygenic risk are likely to derive the most benefit.
  Carlos Iribarren
• Comorbidities and determinants of health on heart failure guideline-directed medical therapy adherence: All of us 2024-11-21
  CONCLUSION: HFrEF and HFpEF GDMT remain underutilized. Future efforts to address comorbidities and system-wide healthcare interventions may improve heart failure GDMT.
  Trinh Do
• Longitudinal changes in lifestyle behaviours and cardiovascular health during the transition to fatherhood: the Dad Bod observational cohort study protocol 2024-11-20
  INTRODUCTION: Despite the importance of the transition to fatherhood as a critical life stage among young adult men, much remains unknown about the factors predictive of ideal cardiovascular health (CVH) and how CVH is impacted as young men face new roles and responsibilities associated with fatherhood.
  Matthew J Landry
• Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction 2024-11-05
  Coronary artery calcium (CAC) scans contain valuable information beyond the Agatston Score which is currently reported for predicting coronary heart disease (CHD) only. We examined whether new artificial intelligence (AI) applied to CAC scans can predict non-CHD events, including heart failure, atrial fibrillation, and stroke. We applied AI-enabled automated cardiac chambers volumetry and calcified plaque […]
  Morteza Naghavi
• Longitudinal Changes in Lifestyle Behaviors and Cardiovascular Health During the Transition to Fatherhood: The Dad Bod Study Rationale and Design 2024-10-14
  BACKGROUND: Despite the importance of the transition to fatherhood as a critical life stage among young adult men, much remains unknown about the factors predictive of ideal cardiovascular health (CVH) and how CVH is impacted as young men face new roles and responsibilities associated with fatherhood.
  Matthew J Landry